During the past decade, Harrogate District Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harrogate District Hospital" #1 sponsor was "University of Leeds" with 4 trials, followed by "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "LEO Pharma" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Medtronic Diabetes" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harrogate District Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "Aneurin Bevan University Health Board" with 1 trials as a collaborator, "Barnsley Hospital NHS Foundation Trust" with 1 trials as a collaborator and "Breast Cancer Trials, Australia and New Zealand" with 1 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Harrogate District Hospital" are "Lymphoma" (3 trials), "Breast Cancer" (2 trials), "Leukemia" (2 trials), "Lung Cancer" (2 trials) and "Mesothelioma" (2 trials). Many other conditions were trialed in "Harrogate District Hospital" in a lesser frequency.

Most popular intervention types in "Harrogate District Hospital" are "Drug" (23 trials), "Other" (9 trials), "Device" (7 trials), "Procedure" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "cyclophosphamide" (3 trials), "fludarabine phosphate" (3 trials), "prednisolone" (3 trials) and "quality-of-life assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Harrogate District Hospital" are 34 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Harrogate District Hospital". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Harrogate District Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Harrogate District Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 8 trials that are defined as “Not Applicable".